Norway· NO-ID_3EC74727-92E9-4EF0-B7FD-E77BA3A2F4E4
Namuscla
A mexiletine product containing mexiletine, registered in Norway by Lupin (Europe) Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Mexiletine is registered in 13 of 19 countries.
Countries holding a registration under ATC C01BB02 (mexiletine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Mexiletine · ATC C01BB02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mexiletine costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mexiletine · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- US United States$1.19 (acquisition cost)
The record
At a glance
FEST (Norway)- Active substance
- Mexiletine
- Manufacturer
- Lupin (Europe) Limited
- Country
- Norway (NO)
- ATC code
- C01BB02
- ATC class
- Mexiletine
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_3EC74727-92E9-4EF0-B7FD-E77BA3A2F4E4
- no_varenummer193543100NOK 34193.5
- gtin4260647610024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
134 interactions on record for mexiletine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mexiletine · interactions on record
134 records
- 7 severe
- 70 moderate
- 5 minor
- 52 info
Most severe, free to view
- TheophyllinC01EB28severe
- BupropionN06AX12severe
- BupropionN07BA02severe
- TheophyllineR03DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mexiletine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMexiletine hydrochloride 200mg (Mexiletine 167mg) capsulesColonis Pharma Ltd
- CzechiaNAMUSCLALupin Europe GmbH, Frankfurt am Main
- FinlandNamusclaLupin Europe GmbH
- FranceNAMUSCLA 167 mg, gélulesLUPIN EUROPE (ALLEMAGNE)
- IrelandNamuscla 167 mg hard capsulesLupin Europe GmbH
- IcelandNamusclaLupin Europe GmbH
- NetherlandsNamuscla 167 mg harde capsulesLupin (Europe) Limited
- PolandNamusclaLupin Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Zunmyro, Zunmyro 200 Mg Hartkapseln
- Denmark · Dopital
- Finland · Dopital
- France · Makmorsa
- United Kingdom (Northern Ireland) · Mexiletine Hydrochloride Clinigen Healthcare, Mexiletine Hydrochloride Waymade
- Hungary · Ritalmex
- Sweden · Dopital
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf8711df-c659-4f74-8c26-9bd17a7fbff2 GET /v1/drugs/bf8711df-c659-4f74-8c26-9bd17a7fbff2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Meksiletin",
"merkevare_id": "ID_3EC74727-92E9-4EF0-B7FD-E77BA3A2F4E4",
"name_form_strength": "Namuscla kaps 167 mg",
"prescription_group": "C"
}See everything about mexiletine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.